有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(2-methylbenzyl)sulfanyl]-5-[(2S)-pyrrolidin-2-yl]-1,3,4-oxadiazole | —— | C14H17N3OS |
|
—— | (5E)-3-[(2R)-2-ethylhexyl]-5-[(4-oxo-2-phenylsulfanylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | —— | C26H27N3O2S3 |
|
—— | 2-[(3-fluorophenyl)methylsulfanyl]-5-[(2S)-pyrrolidin-2-yl]-1,3,4-oxadiazole | —— | C13H14FN3OS |
|
—— | 6-methyl-5-[[5-[(2S)-pyrrolidin-2-yl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-1H-pyrimidine-2,4-dione | —— | C12H15N5O3S |
|
—— | 2-[(4-fluorobenzyl)sulfanyl]-5-[(2S)-pyrrolidin-2-yl]-1,3,4-oxadiazole | —— | C13H14FN3OS |
|
—— | 2-({5-[(2S)-pyrrolidin-2-yl]-1,3,4-oxadiazol-2-yl}sulfanyl)acetamide | —— | C8H12N4O2S |
|
—— | (3S)-N-[(E)-[4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-3-nitrophenyl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide | —— | C19H16N6O5S |
|
—— | (5E)-3-[(2S)-2-ethylhexyl]-5-[(4-oxo-2-phenylsulfanylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | —— | C26H27N3O2S3 |
|
—— | N-[2-[(5E)-5-[(2-fluorophenyl)methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]ethyl]-2-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide | —— | C20H15FN4O4S3 |
|
—— | (2R,5Z)-2-cyclopentyl-5-[(4-methylsulfanylphenyl)methylidene]cyclopentan-1-one | —— | C18H22OS |
|
—— | (Z)-phenyl(2-(p-tolylthio)vinyl)sulfane | —— | C15H14S2 |
|
—— | 2-[(Z)-2-(2-chlorophenyl)ethenyl]-3-phenylsulfanylquinoxaline | —— | C22H15ClN2S |
|
—— | (1S)-N-ethyl-1-[2-(4-fluorophenyl)sulfanylphenyl]ethanamine | —— | C16H18FNS |
|
—— | (1S)-1-(4-ethylsulfanylphenyl)-N-methylethanamine | —— | C11H17NS |
|
—— | (1R)-1-[4-[(2S)-butan-2-yl]sulfanyl-3-fluorophenyl]-N-ethylethanamine | —— | C14H22FNS |
|
—— | (1S)-N-methyl-1-(2-pyridin-2-ylsulfanylphenyl)ethanamine | —— | C14H16N2S |
|
—— | (1S)-1-(2-ethylsulfanylphenyl)-N-methylethanamine | —— | C11H17NS |
|
—— | (1R)-1-[2-(2-fluorophenyl)sulfanylphenyl]-N-methylethanamine | —— | C15H16FNS |
|
—— | (1S)-N-ethyl-1-[4-(4-methylphenyl)sulfanylphenyl]ethanamine | —— | C17H21NS |
|
—— | (1S)-1-[2-[(2S)-butan-2-yl]sulfanyl-5-fluorophenyl]-N-ethylethanamine | —— | C14H22FNS |
|
—— | (1R)-N-ethyl-1-[4-(4-methylphenyl)sulfanylphenyl]ethanamine | —— | C17H21NS |
|
—— | (1R)-1-[4-(3-methoxyphenyl)sulfanylphenyl]-N-methylethanamine | —— | C16H19NOS |
|
—— | N-[(1R)-1-[4-[(2R)-butan-2-yl]sulfanyl-3-fluorophenyl]ethyl]propan-1-amine | —— | C15H24FNS |
|
—— | (1S)-1-[4-[(2R)-butan-2-yl]sulfanyl-3-fluorophenyl]-N-ethylethanamine | —— | C14H22FNS |
|
—— | (1S)-1-[4-[(2S)-butan-2-yl]sulfanyl-3-fluorophenyl]-N-ethylethanamine | —— | C14H22FNS |
|
—— | 2-[(2-fluorobenzyl)sulfanyl]-5-[(2S)-pyrrolidin-2-yl]-1,3,4-oxadiazole | —— | C13H14FN3OS |
|
—— | N-[(1R)-1-(2-tert-butylsulfanylphenyl)ethyl]propan-1-amine | —— | C15H25NS |
|
—— | N-[(1R)-1-(2-phenylsulfanylphenyl)ethyl]propan-1-amine | —— | C17H21NS |
|
—— | (1S)-1-[2-(2-fluorophenyl)sulfanylphenyl]-N-methylethanamine | —— | C15H16FNS |
|
—— | N-[(E)-(4-methylsulfanylphenyl)methylideneamino]-N'-[(Z)-(4-methylsulfanylphenyl)methylideneamino]butanediamide | —— | C20H22N4O2S2 |
|
—— | [amino-(4-fluoroanilino)methylidene]-[4-[(4-chlorophenyl)sulfanylmethyl]-6-oxo-1H-pyrimidin-2-yl]azanium | —— | C18H16ClFN5OS+ |
|
—— | [(2R)-3-chloro-2-hydroxypropyl] carbamimidothioate | —— | C4H9ClN2OS |
|
—— | 2-[(Z)-3-cyanoprop-2-enyl]sulfanyl-4,6-dimethylpyridine-3-carbonitrile | —— | C12H11N3S |
|
—— | 3-cyclohexyl-1-[(4R)-5,5-dimethyl-3-[(E)-(4-methylsulfanylphenyl)methylideneamino]-2-sulfanylidene-1,3-thiazolidin-4-yl]-1-hydroxyurea | —— | C20H28N4O2S3 |
|
—— | N-[3-(methylthio)phenyl]imidodicarbonimidic diamide | —— | C9H13N5S |
|
—— | (E)-[amino(pyridin-4-yl)methylidene]-[2-(4-methylphenyl)sulfanylacetyl]oxyazanium | —— | C15H16N3O2S+ |
|
—— | methyl N'-[(1R)-3,3-dimethylcyclohexyl]carbamimidothioate | —— | C10H20N2S |
|
—— | (2E)-2-{2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-1-phenylethylidene}hydrazinecarbothioamide | —— | C15H17N5S2 |
|
—— | (2E)-2-{2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-1-phenylethylidene}hydrazinecarboxamide | —— | C15H17N5OS |
|
—— | (E)-[amino(diaminomethylideneazaniumyl)methylidene]-[4-(trifluoromethylsulfanyl)phenyl]azanium | —— | C9H12F3N5S+2 |
|
—— | (E)-[amino(diaminomethylideneazaniumyl)methylidene]-[4-(difluoromethylsulfanyl)phenyl]azanium | —— | C9H13F2N5S+2 |
|
—— | N-[(Z)-(4-methylsulfanylphenyl)methylideneamino]-2-pyrimidin-2-ylsulfanylacetamide | —— | C14H14N4OS2 |
|
—— | (4E)-3-methyl-4-[(4-methylsulfanylphenyl)methylidene]-1,2-oxazol-5-one | —— | C12H11NO2S |
|
—— | [Amino(diaminomethylideneazaniumyl)methylidene]-(2-methylsulfanylphenyl)azanium | —— | C9H15N5S+2 |
|
—— | 7'-methyl-2'-(methylthio)-1',4',6',7'-tetrahydro-8'H-spiro[cyclopentane-1,5'-[1,2,4]triazolo[1,5-d][1,2,4,6]tetrazepine]-8'-thione | —— | C10H17N6S2+ |
|
—— | (Methyl-oxidooxy-oxo-lambda6-sulfanylidene)oxidanium | —— | CH4O4S |
|
—— | (E)-but-2-ene-2,3-dithiol | —— | C4H8S2 |
|
—— | 3-Mercaptopropyl(dimethoxy)methyl silane | —— | C6H14O2SSi |
|
—— | (1R)-1-[4-(4-bromophenyl)sulfanyl-3-fluorophenyl]-N-methylethanamine | —— | C15H15BrFNS |
|
—— | (1R)-N-ethyl-1-[5-fluoro-2-(1,3,4-thiadiazol-2-ylsulfanyl)phenyl]ethanamine | —— | C12H14FN3S2 |
|